In this talk Maria Kyrgiou reviews the evidence on how best to manage women with histologically proven CIN 2.
FInding the balance between conservative management and treatment is a challange for colposcopists particualrly when CIN 2 has been diagnosed. The evidence for possible helpful criteria including age, fertility status, HPV genotypes and newer moilecular markers and microbiomes is explored in this really useful review.